Litcius/Paper detail

Randomized controlled trial of perhexiline on regression of left ventricular hypertrophy in patients with symptomatic hypertrophic cardiomyopathy (RESOLVE-HCM trial)

Rajiv Ananthakrishna, Sau L. Lee, Jonathon Foote, Benedetta C. Sallustio, G Binda, Arduino A. Mangoni, Richard Woodman, Christopher Semsarian, John D. Horowitz, Joseph B. Selvanayagam

2021American Heart Journal25 citationsDOI

Topics & Concepts

MedicineHypertrophic cardiomyopathyCardiologyInternal medicineLeft ventricular hypertrophyClinical endpointPlaceboHeart failureCardiomyopathySurrogate endpointRandomized controlled trialMuscle hypertrophyBlood pressurePathologyAlternative medicineCardiomyopathy and Myosin StudiesCardiovascular Function and Risk FactorsCardiac Imaging and Diagnostics